Skip to main content
. 2017 Jul 18;8(40):68317–68328. doi: 10.18632/oncotarget.19344

Figure 1. Study design flow chart.

Figure 1

The study consisted of three sections: a systematic literature review to select candidate miRNAs, a training phase for screening candidate miRNAs and constructing diagnostic models, and a validation phase for confirming optimal miRNAs/diagnostic models.